« Back to Recent News

Introducing ZETONNA (ciclesonide) Nasal Aerosol: A New Dry Option for Allergic Rhinitis
Feb 27, 2013

Date & Time: February 27th, 2013, 6:30pm

Location: Sitar Indian Cuisine

Address: 420 Jordan Ln NW Huntsville, AL 35805 (256) 536-3360

Hosted By: Sunovion Pharmaceuticals (Bob Godwin) and aAPI

Message: Please register for this program today. 
1. RSVP thru the pingg e-mail you received. 
2. Contact Shashi Kumar at 
3. Click the link below to register on our aAPI website.  
Shashi Kumar MD 
In accordance with the PhRMA code on interactions with healthcare professionals, attendance at this educational program is limited to healthcare professionals. Accordingly, attendance by spouses and guests is not appropriate and associated expenses will not be reimbursed. 
ZETONNA® (ciclesonide) Nasal Aerosol is a corticosteroid indicated for the treatment of symptoms associated with seasonal and perennial allergic rhinitis in adults and adolescents 12 years of age and older. 
IMPORTANT SAFETY INFORMATIONIn clinical studies local nasal effects of epistaxis, ulcerations, and nasal septal perforations were observed with 
ZETONNA® (ciclesonide) Nasal Aerosol. In the short-term and long term trials combined, nasal septal perforations were reported in 2 patients of 2335 treated with ZETONNA Nasal Aerosol compared with none of 892 treated with placebo. Both perforations occurred in 2 week SAR trials while none occurred in the longer term trials. In clinical trials with another formulation of ciclesonide, the development of localized infections of the nose or pharynx with Candida albicans has occurred. Corticosteroids can interfere with wound healing.Prior to initiating therapy, examine patients for evidence of septal perforation, erosions, ulceration, nasal surgery, and trauma. Avoid spraying ZETONNA Nasal Aerosol directly onto the nasal septum. Avoid use in patients with recent septal perforation, nasal erosion, nasal ulcers, nasal surgery, or nasal trauma. Monitor patients periodically for signs of adverse reactions on the nasal mucosa. Discontinue ZETONNA Nasal Aerosol if erosions, ulcerations or perforations occur.Nasal and inhaled corticosteroids may result in the development of glaucoma and cataracts. Monitor patients closely with a change in vision or with a history of increased intraocular pressure, glaucoma, or cataracts.ZETONNA Nasal Aerosol is contraindicated in patients with a known hypersensitivity to ciclesonide or any of the ingredients of ZETONNA Nasal Aerosol. Cases of hypersensitivity reactions following administration of ciclesonide with manifestations such as angioedema, with swelling of the lips, tongue and pharynx have been reported.